A Phase I/II Study of Intratumoral Injection of SD-101

Clinical trial NCT02254772 · COMPLETED

Trial details

NCT number: NCT02254772
Sponsor: Robert Lowsky
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma

Start date: 2014-09-01
Primary completion: 2016-11-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.